FENNELL GEORGE 4
4 · IDEXX LABORATORIES INC /DE · Filed Feb 11, 2026
Research Summary
AI-generated summary of this filing
IDEXX (IDXX) EVP George Fennell Exercises Options, Sells Shares
What Happened
- George Fennell, Executive Vice President of IDEXX Laboratories (IDXX), exercised stock options and sold most of the resulting shares. He exercised 1,476 options on 2026-02-09 and 11,345 options on 2026-02-10 at an exercise price of $67.85 per share (total exercise cost $869,905).
- On 2026-02-10 he sold 11,345 shares in multiple open-market trades at prices ranging roughly $642.60 to $650.32 per share for aggregate gross proceeds of about $7,336,993. After subtracting the exercise cost, the approximate pre-tax spread was ~$6,467,088.
Key Details
- Transaction dates: exercises on 2026-02-09 and 2026-02-10; open-market sales on 2026-02-10.
- Exercise price: $67.85 per share (total paid ≈ $869,905). Sale price range: ≈ $642.60–$650.32; total sale proceeds ≈ $7.34M.
- Shares exercised: 12,821 (1,476 + 11,345). Shares sold: 11,345.
- Shares owned after the transactions: not specified in the Form 4 filing.
- Notable footnotes: F1–F7 give weighted-average price ranges for the different sale batches; F8 and F9 note the option grants and vesting (1,476-share grant vested Feb 14, 2021; 11,345-share grant vested in installments beginning Feb 14, 2017).
- Filing timeliness: Form 4 was filed 2026-02-11 for transactions occurring 2026-02-09/10; no late-filing indication in the report.
Context
- This is a common "exercise + sell" pattern (option exercise followed by immediate open‑market sales). The filing also shows derivative dispositions at $0 for the exercised option lots, which typically reflects shares surrendered/withheld to cover exercise cost or tax obligations (i.e., a sell-to-cover or net share settlement).
- Transaction codes: M = option exercise/conversion; S = open-market sale.
- These actions are factual insider transactions and do not, by themselves, indicate the insider’s broader view of the company.
Insider Transaction Report
Form 4
FENNELL GEORGE
Executive Vice President
Transactions
- Exercise/Conversion
Common Stock
2026-02-09$67.85/sh+1,476$100,147→ 9,823 total - Exercise/Conversion
Common Stock
2026-02-10$67.85/sh+11,345$769,758→ 21,168 total - Sale
Common Stock
[F1]2026-02-10$643.00/sh−1,130$726,587→ 20,038 total - Sale
Common Stock
[F2]2026-02-10$644.02/sh−397$255,674→ 19,641 total - Sale
Common Stock
[F3]2026-02-10$645.25/sh−2,161$1,394,388→ 17,480 total - Sale
Common Stock
[F4]2026-02-10$646.23/sh−2,782$1,797,800→ 14,698 total - Sale
Common Stock
[F5]2026-02-10$647.21/sh−1,060$686,039→ 13,638 total - Sale
Common Stock
[F6]2026-02-10$648.78/sh−966$626,721→ 12,672 total - Sale
Common Stock
[F7]2026-02-10$649.26/sh−2,809$1,823,771→ 9,863 total - Sale
Common Stock
2026-02-10$650.32/sh−40$26,013→ 9,823 total - Exercise/Conversion
Incentive Stock Option (right-to-buy)
[F8]2026-02-09−1,476→ 0 totalExercise: $67.85Exp: 2026-02-13→ Common Stock (1,476 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
[F9]2026-02-10−11,345→ 0 totalExercise: $67.85Exp: 2026-02-13→ Common Stock (11,345 underlying)
Footnotes (9)
- [F1]Represents the weighted average price of the shares sold ranging from a low of $642.595 to a high of $643.47 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- [F2]Represents the weighted average price of the shares sold ranging from a low of $643.65 to a high of $644.47 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- [F3]Represents the weighted average price of the shares sold ranging from a low of $644.75 to a high of $645.60 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- [F4]Represents the weighted average price of the shares sold ranging from a low of $645.80 to a high of $646.71 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- [F5]Represents the weighted average price of the shares sold ranging from a low of $646.825 to a high of $647.69 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- [F6]Represents the weighted average price of the shares sold ranging from a low of $648.02 to a high of $649.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- [F7]Represents the weighted average price of the shares sold ranging from a low of $649.05 to a high of $649.72 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- [F8]Grant of option to buy 1,476 shares of Issuer common stock that vested on February 14, 2021.
- [F9]Grant of option to buy 11,345 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2017.
Signature
/s/ Lily J. Lu, Attorney-in-Fact for George Fennell|2026-02-11